Draig Therapeutics

Draig Therapeutics is a psychiatric medicines startup developing AMPA/GABA-targeted treatments for depression; it raised $65 million in Series B funding led by Deep Track Capital, with participation from Janus Henderson Investors, Marshall Wace, British Business Bank, and Jefferson Life Sciences.